novo nordisk - Search News

News

Novo Nordisk Cuts Guidance

The Wall Street Journal on MSN · 1h

Novo Nordisk Investors Breathe Sigh of Relief Despite Guidance Hit From Copycat Drugs

Shares rallied Wednesday even after the drugmaker lowered its full-year guidance as alternative versions of its blockbuster weight-loss and diabetes drugs in the U.S. hold back its sales.

Barron's on MSN · 3h

Novo Nordisk Cuts Guidance as Weight-Loss Drug Sales Slow. Why the Stock Is Up.

Novo Nordisk stock rose after the Danish pharma giant posted better-than-expected quarterly earnings, but cuts its guidance for the year. For the full year, the company now expects sales growth between 13% and 21%.

CNBC on MSN · 6h

Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Novo Nordisk shares up on hopes for US Wegovy recovery

MarketWatch on MSN · 2h

Novo Nordisk shares are rising after the company cut its outlook. It’s been that kind of year.

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But that’s reflective of the tough times the Danish maker of Ozempic and other weight-loss drugs has had.

Reuters on MSN · 3h

Novo Nordisk shares up on hopes for US Wegovy recovery after forecasts cut

Obesity drugmaker Novo Nordisk cut its sales forecasts on Wednesday for the first time since the launch of its Wegovy weight-loss drug four years ago, but its shares rose about 6% as the company anticipates a recovery in its biggest market in the U.

Yahoo Finance · 48m

Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand

Shares in Novo Nordisk were still up after Q1 2025 witnessed a total revenue jump by 18%, compared to Q1 2024.

2hon MSN

Drugmaker Novo Nordisk drops gender representation requirements in the US

COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk said on Wednesday it would drop gender representation requirements for ...

1h

Novo Nordisk Q1 2025: One Of The Best Deals You Can Get Right Now

Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...

3hon MSN

Trending tickers: AMD, Novo Nordisk, Rivian, Super Micro and Trainline

Novo Nordisk (NVO, NOVO-B.CO) said first-quarter sales of its first-to-market weight-loss drug Wegovy were 17.36bn Danish ...

2hon MSN

Novo Nordisk's CFO sceptical Trump executive order on drug manufacturing can cut timelines

Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...

The Manila Times1d

Novo Nordisk A/S: ECO 2025 - Novo Nordisk semaglutide data shows new health benefits across serious chronic diseases

Semaglutide is marketed under the brand names Wegovy ® (once-weekly semaglutide 2.4 mg injection), Ozempic ® (once-weekly ...

15h

Top Analyst Reports for Novo Nordisk, Honeywell & American Tower

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Honeywell ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results